Home  /  Resource Library  /  Comparison between Venetoclax-based and Bruton Tyrosine-Kinase inhibitors based therapy as upfront treatment of chronic lymphocytic leukemia (CLL): A systematic review and network meta-analysis

Comparison between Venetoclax-based and Bruton Tyrosine-Kinase inhibitors based therapy as upfront treatment of chronic lymphocytic leukemia (CLL): A systematic review and network meta-analysis

Systematic review compared the effectiveness of venetoclax based treatments to BTK inhibitors for first line treatment of CLL. (Abstract only)